V
Vector BioMed
Superior Gene Delivery Systems Empowering Tomorrow’s Gene Medicine Cures
About Vector BioMed
Vector BioMed specializes in the development and commercialization of gene therapies through custom Lentiviral vector manufacturing. The company serves researchers and pharmaceutical companies by providing tailored solutions for gene delivery, particularly for CAR T cell therapies and Stem Cell gene therapies. Operating in the biotechnology and pharmaceutical markets, Vector BioMed's business model revolves around offering bespoke vector design and GMP (Good Manufacturing Practice) manufacturing services. Revenue is generated through the provision of these specialized services, which include designing optimal Lentiviral vector candidates to meet specific therapeutic targets. The company prides itself on delivering high-quality, safe, and effective gene delivery systems.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Headquarters
- Gaithersburg, United States
- Open positions
- 2
- Dealroom signal
- 22.9/100
- Industry
- Health
- Sector
- Health, Hard Tech
- Business model
- Manufacturing
- Client focus
- b2b
- Links
- Website
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| EARLY VC✓Equity / VC | Dec 2022 | $15M | $60M | Casdin Capital · Viking Global Investors | ↗ |
Growth signals
Latest recorded traffic for Vector BioMed is 2K monthly website visits, up 66.7% over the last three months.
Open positions
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A2 investors entered at this stage
Casdin Capital
Viking Global Investors
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Vector BioMed on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Vector BioMed’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.







